Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma
Aliment Pharmacol Ther
.
2024 Jun;59(11):1462-1464.
doi: 10.1111/apt.17985.
Epub 2024 Apr 21.
Authors
Enrico N De Toni
1
,
Julia Mayerle
1
,
Bettina Oehrle
1
,
Max Seidensticker
2
,
Lorenza Rimassa
3
4
,
Alexander Philipp
1
,
Daniel Roessler
1
,
Najib Ben Khaled
1
Affiliations
1
Department of Medicine 2, University Hospital, LMU Munich, Munich, Germany.
2
Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
3
Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
4
Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.
PMID:
38643505
DOI:
10.1111/apt.17985
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular* / therapy
Disease Progression*
Humans
Immunotherapy* / methods
Liver Neoplasms* / therapy
Research Design
Treatment Outcome